Among the most active markets in private equity, the healthcare industry provides ripe investment opportunities for funds that can navigate the complex regulatory landscape. As the industry’s top-ranked law firm for health and life sciences ventures, we understand key regulatory issues, communicate clearly with regulators and counsel on the other side of the table, and close deals in a cost-effective, timely manner to maximize value.
Partnering with you to create the future of the industry
We collaborate with those at the forefront of health industry innovation to foster the unique partnerships and business ventures that are transforming healthcare. Our cross-functional legal counsel removes the false barriers that often arise between transactional and regulatory issues. Thus, we’re able to minimize due diligence redundancies, assist financing sources so that legal questions are handled appropriately, and move deals swiftly from negotiation to implementation.
Our experienced private equity team has advised on hundreds of healthcare deals covering the gamut of clinics, hospitals, inpatient/outpatient services, practice management, laboratory services, information technology, managed care, devices and supplies, business processing outsourcing, revenue cycle management and more.
We are the only firm ranked in the top tier by all of the major rankings and directories, including Chambers USA, which has named us “Health Law Firm of the Year” three times. We work hand-in-hand with our top-ranked private equity practice, which means private equity funds can rely on us as a comprehensive legal solution.
Our clients have the confidence to execute because they know they have the full weight of the leading health
care law firm behind them. We offer counsel on the full range of investment and financing activities, including growth investments and buy-and-build strategies; control, non-control and minority investments; buyouts and recapitalizations; auction processes; strategic dispositions and exit strategies; and bankruptcy, out-of-court restructurings and workouts.
Skilled at helping private equity firms and their portfolio companies acquire distressed assets, our global restructuring and insolvency team offers strategic advice on navigating the peculiarities associated with asset sales in Chapter 11 and 7 bankruptcy cases, UCC Article 9 foreclosures and out-of-court restructurings. Our clients rely on our experience when acquiring assets through a debtor’s plan of reorganization in Chapter 11 bankruptcy cases because of our skilled handling of the various associated legal complications. We’re also successful with section 363 bankruptcy sales and pursuing “stalking horse” status for our clients.
Our finance team provides critical legal services during healthcare buyout transactions. Our solid relationships with numerous lenders active in the private equity marketplace allow us to think creatively in evaluating financing approaches. We are particularly skilled at tailoring multilayered financing packages to meet the unique characteristics of each deal, thanks to our vast experience with structuring acquisitions, recapitalization, refinancing and disposition of portfolio companies, as well as transactions for add-ons and restructurings.
We also serve as general counsel for portfolio companies, advising on major transactions and day-to-day legal matters, as well as providing efficiency and continuity for platform acquisitions, bolt-on transactions, operational and compliance issues, and sales.
We collaborate with those at the forefront of health industry innovation to foster the unique partnerships and business ventures that are transforming healthcare.
New York, NY / McDermott Event / October 25,2019
Pubblicazioni / October 23, 2019
Podcasts / October 7, 2019
London, United Kingdom / McDermott Event / September 26, 2019
Video / August 12, 2019
Video / August 6, 2019
Video / July 22, 2019
International News / April 2019
1
2
Healthcare Business International / October 31, 2019
New York / Press Releases / October 24, 2019
MedTech Drive / October 14, 2019
Hospitals, Manufacturers Could Donate Cybersecurity Software under Proposed Regs
New York / Press Releases / October 10, 2019
McDermott Convenes Hottest Dealmakers At Private Equity Forum
London / Press Releases / September 23, 2019
McDERMOTT TO HOST EUROPEAN HEALTHCARE PRIVATE EQUITY LEADERSHIP FORUM 2019
London / Press Releases / September 18, 2019
McDermott to Host European Healthcare Private Equity Leadership Forum 2019
Wall Street Journal / September 13, 2019
In Their Own Words with McDermott Will & Emery’s Ira Coleman
1
2
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.